- Previous Close
3.8300 - Open
3.6700 - Bid 3.6700 x 100
- Ask 4.1200 x 100
- Day's Range
3.6700 - 3.6700 - 52 Week Range
2.3200 - 5.6900 - Volume
7,476 - Avg. Volume
185,694 - Market Cap (intraday)
190.636M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
www.wellgisticshealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WGRX
View MorePerformance Overview: WGRX
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WGRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WGRX
View MoreValuation Measures
Market Cap
198.95M
Enterprise Value
223.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.98
Price/Book (mrq)
29.54
Enterprise Value/Revenue
12.30
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-37.82%
Return on Assets (ttm)
-13.32%
Return on Equity (ttm)
-357.65%
Revenue (ttm)
18.13M
Net Income Avi to Common (ttm)
-6.86M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
1.03M
Total Debt/Equity (mrq)
371.21%
Levered Free Cash Flow (ttm)
6.37M